Overview

Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety and efficacy of mecamylamine for the core symptoms of autism.
Phase:
Phase 1
Details
Lead Sponsor:
Ohio State University
Collaborator:
Autism Speaks
Treatments:
Mecamylamine